Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Reiterates Buy on RxSight, Maintains $22 Price Target

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.
byBenzinga Newsdesk
February 7, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0